Predictive Value of CHADS and CHADS-VASc Scores for Coronary Artery Lesions and In-hospital Prognosis of Patients with Acute ST-segment Elevation Myocardial Infarction

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2021 Sep 16

PMID 34525958

Citations 3

Authors

Xiaoli Li

Zhen Zeng

Xinchun Yang

Hongjiang Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the predictive value of CHADS and CHADS-VASc scores for coronary artery lesions and in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction (STEMI).

Methods: A total of 524 patients who were diagnosed with STEMI from January 2016 to August 2017 were retrospectively reviewed. The correlation between CHADS and CHADS-VASc scores with the patients' clinical data, number of coronary lesions, Gensini scores, the target vessel and hospitalization time and in-hospital adverse events (AEs) was analyzed.

Results: The number of coronary lesions in STEMI patients was mainly single and double lesions. The CHADS and CHADS-VASc scores were not meaningful for predicting the number of coronary lesions. However, for left main coronary artery lesion, CHADS score was significantly increased when the number increased (P < 0.05), but CHADS-VASc score showed no statistical difference (P > 0.05). The incidence of target lesions in STMEI patients was mainly left anterior descending coronary artery (LAD) and right coronary artery (RCA). The two scores were not meaningful for predicting target lesions (P > 0.05). For the severity of coronary lesions, there was positive correlation between CHADS score with Gensini score (P < 0.05), but no exact correlation between CHADS-VASc score and Gensini score (P > 0.05). The stratifications of CHADS score and CHADS-VASc score were significantly associated with hospitalization time and adverse events during hospitalization (P < 0.05). The high score group had longer hospitalization time and more AEs during hospitalization than the low score group and the middle group statistically (P < 0.05).

Conclusion: CHADS score had a certain value to predict the severity of coronary lesion and the presence of left main coronary artery in STEMI. The CHADS-VASc score had no predictive ability to do it. There was no significant value in predicting the number of coronary lesions and the location of the target lesions in STEMI patients. However, both scores had the predictive ability for patient hospitalization and AEs during hospitalization.

Citing Articles

Predictive value of CHA DS -VASc score for in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary PCI.

Sun Y, Ren J, Wang W, Wang C, Li L, Yao H Clin Cardiol. 2023; 46(8):950-957.

PMID: 37430484 PMC: 10436800. DOI: 10.1002/clc.24071.

Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction.

Fang C, Chen Z, Zhang J, Jin X, Yang M Int J Clin Pract. 2022; 2022:3659381.

PMID: 36225534 PMC: 9525758. DOI: 10.1155/2022/3659381.

Study on the predictive ability of emergency CHADS score and CHADS-VASc score for coronary artery disease and prognosis in patients with acute ST-segment elevation myocardial infarction.

Huang X, Lv H, Liu Z, Liu Y, Yang X J Thorac Dis. 2022; 14(7):2611-2620.

PMID: 35928606 PMC: 9344425. DOI: 10.21037/jtd-22-763.

References

Verma A, Kilicaslan F, Marrouche N, Minor S, Khan M, Wazni O . Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol. 2004; 15(11):1265-70. DOI: 10.1046/j.1540-8167.2004.04352.x. View

Neumar R, Shuster M, Callaway C, Gent L, Atkins D, Bhanji F . Part 1: Executive Summary: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015; 132(18 Suppl 2):S315-67. DOI: 10.1161/CIR.0000000000000252. View

Hong H, Kim Y, Cha M, Kim J, Lee D, Lee H . Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation. Eur J Neurol. 2011; 19(2):284-90. DOI: 10.1111/j.1468-1331.2011.03518.x. View

Roy S, Abu Azam S, Khalequzzaman M, Ullah M, Rahman M . GRACE and TIMI risk scores in predicting the angiographic severity of non-ST elevation acute coronary syndrome. Indian Heart J. 2019; 70 Suppl 3:S250-S253. PMC: 6309119. DOI: 10.1016/j.ihj.2018.01.026. View

. ST-segment elevation myocardial infarction. Nat Rev Dis Primers. 2019; 5(1):40. DOI: 10.1038/s41572-019-0094-z. View

Vanek T, Kolesar M, Nejedly M, Jirmar R . Rescue peri-operative management of the patient with giant electrical storm and severe left ventricular dysfunction: support by levosimendan and intraaortic balloon counterpulsation. Interact Cardiovasc Thorac Surg. 2008; 7(4):648-50. DOI: 10.1510/icvts.2008.176883. View

Goto S, Bhatt D, Rother J, Alberts M, Hill M, Ikeda Y . Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008; 156(5):855-63, 863.e2. DOI: 10.1016/j.ahj.2008.06.029. View

Lala A, Desai A . The role of coronary artery disease in heart failure. Heart Fail Clin. 2014; 10(2):353-65. DOI: 10.1016/j.hfc.2013.10.002. View

Ryu K, Park H, Park S, Shon H, Ryu K, Lee D . Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases. J Geriatr Cardiol. 2015; 12(3):208-17. PMC: 4460162. DOI: 10.11909/j.issn.1671-5411.2015.03.014. View

10.

Gage B, Waterman A, Shannon W, Boechler M, Rich M, Radford M . Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285(22):2864-70. DOI: 10.1001/jama.285.22.2864. View

11.

Tasolar H, Cetin M, Balli M, Bayramoglu A, Otlu Y, Turkmen S . CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events. Anatol J Cardiol. 2016; 16(10):742-748. PMC: 5324933. DOI: 10.14744/AnatolJCardiol.2015.6593. View

12.

Fuster V, Ryden L, Cannom D, Crijns H, Curtis A, Ellenbogen K . 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice.... J Am Coll Cardiol. 2011; 57(11):e101-98. DOI: 10.1016/j.jacc.2010.09.013. View

13.

Kim Y, Cha M, Kim J, Lee D, Lee H, Nam C . Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS₂ score. Thromb Haemost. 2011; 105(4):712-20. DOI: 10.1160/TH10-11-0692. View

14.

Jeong Y, Jeong M, Kim S, Rhew S, Ahn Y, Kim J . CHA2DS2-VASc scoring system as an initial method for screening high-risk patients in acute myocardial infarction. Int J Cardiol. 2014; 174(3):777-80. DOI: 10.1016/j.ijcard.2014.04.055. View

15.

Cinar T, Hayiroglu M, Tanik V, Arugaslan E, Keskin M, Uluganyan M . The predictive value of the CHA2DS2-VASc score in patients with mechanical mitral valve thrombosis. J Thromb Thrombolysis. 2018; 45(4):571-577. DOI: 10.1007/s11239-018-1640-3. View

16.

Kim Y, Cha M, Kim J, Lee D, Lee H, Nam C . Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation. Stroke. 2011; 42(4):930-4. DOI: 10.1161/STROKEAHA.110.602987. View

17.

Faroux L, Guimaraes L, Wintzer-Wehekind J, Junquera L, Ferreira-Neto A, Del Val D . Coronary Artery Disease and Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019; 74(3):362-372. DOI: 10.1016/j.jacc.2019.06.012. View

18.

Neeland I, Patel R, Eshtehardi P, Dhawan S, McDaniel M, Rab S . Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J. 2012; 164(4):547-552.e1. PMC: 3913177. DOI: 10.1016/j.ahj.2012.07.007. View

19.

Uysal O, Turkoglu C, Duran M, Gungor Kaya M, Sahin D, Gur M . Predictive value of newly defined CHA2DS2-VASc-HSF score for severity of coronary artery disease in ST segment elevation myocardial infarction. Kardiol Pol. 2016; 74(9):954-60. DOI: 10.5603/KP.a2016.0054. View

20.

Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H . Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2009; 137(2):263-72. DOI: 10.1378/chest.09-1584. View